Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jan. 29, 2022	Jan. 30, 2021	Feb. 01, 2020
OPERATING ACTIVITIES
Net income	$ 36,844,000	$ (47,483,000)	$ 35,897,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	12,356,000	14,681,000	15,485,000
Provision For Doubtful Accounts	429,000	306,000	524,000
Purchase premium and premium amortization	(332,000)	(691,000)	(694,000)
Gain on sale of asset	0	(2,298,000)	0
Share Based Compensation	4,090,000	4,092,000	4,669,000
Deferred income taxes	(3,194,000)	3,030,000	2,120,000
Loss on disposal of property and equipment	629,000	461,000	837,000
Impairment	(901,000)	(13,702,000)	(470,000)
Changes in operating assets and liabilities which provided (used) cash:
Accounts receivable	(3,499,000)	(26,935,000)	1,525,000
Merchandise inventories	(40,784,000)	31,242,000	4,220,000
Prepaid and other assets	(505,000)	(1,596,000)	5,072,000
Operating lease right-of-use asstes and liabilities	(3,855,000)	(2,611,000)	(9,803,000)
Accrued income taxes	(1,118,000)	335,000	1,703,000
Accounts payable, accrued expenses and other liabilities	57,826,000	(16,945,000)	(8,629,000)
Net cash provided by operating activities	59,788,000	(30,710,000)	53,396,000
INVESTING ACTIVITIES
Capital expenditures	(4,105,000)	(13,956,000)	(8,306,000)
Purchase of short-term investments	(141,937,000)	(74,041,000)	(218,345,000)
Sales of short-term investments	121,110,000	149,298,000	205,375,000
Purchase of Other Assets	(400,000)	0	(1,357,000)
Sales Of Other Assets	0	(3,205,000)	0
Net cash used in investing activities	(25,332,000)	64,506,000	(22,633,000)
FINANCING ACTIVITIES
Dividends paid	(9,972,000)	(7,912,000)	(32,592,000)
Repurchase of common stock	(22,033,000)	(19,654,000)	(9,605,000)
Proceeds from lines of credit	0	34,000,000	0
Payments to lines of credit	0	(34,000,000)	0
Proceeds from employee stock purchase plan	204,000	391,000	626,000
Net cash provided used in financing activities	(31,801,000)	(27,175,000)	(41,571,000)
Net increase in cash and cash equivalents	2,655,000	6,621,000	(10,808,000)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	21,022,000	14,401,000	25,209,000
Cash, Cash Equivalents and Restricted Cash at End of Period	23,677,000	21,022,000	14,401,000
Change in Accrued PPE	657,000	343,000	2,828,000
Change in Accrued Treasury Stock	$ 0	$ 0	$ 818,000